This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (8)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Although topical corticosteroids are recommended for treatment of patchy alopecia areata,^1-2 there is no good double-blind, controlled trial to support this treatment. We therefore designed this randomized, double-blind, placebo-controlled study to assess the efficacy of 0.25% desoximetasone cream in this disease.

Patients and Methods

This study included 70 patients with patchy alopecia areata who did not receive any treatment for at least 1 month prior to the study. Patients younger than 15 years and pregnant women were excluded.

Subjects were assigned randomly to apply either 0.25% desoximetasone or placebo twice a day for 12 weeks. They were observed every 4 weeks to record progress of hair regrowth, adverse effects, and compliance. Before and after treatment, the bald areas were traced onto transparent film to calculate the percentage of regrowth.

The primary outcome criterion for success of treatment was complete hair growth. Patients with 25% regrowth or less were classified as having no improvement; . . . [Full Text of this Article]

Results

Comment

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is There a Role for Steroid Creams in Treatment of Alopecia Areata?
Journal Watch Dermatology 2000;2000:5-5.
FULL TEXT